BSN Medical Proshield N-95 Face Mask, Box of 50

Areas of use
Provides a high level of respiratory protection for clinicians/patients who are
potentially exposed to Tuberculosis (TB) or other infectious diseases.

Features and Benefits

• The ProShield N-95 fluid resistant face mask has orange single pleat particulate respirator with bands.

Bacterial Filtration Efficiency (BFE)

• With a Bacterial Filtration Efficiency (BFE) of greater than 99% for media greater than 3 microns, the ProShield N-95 fluid resistant face mask provides superior protection from potential infection.

BFE is an independent test conducted by Nelson Laboratories that measures the effectiveness of face mask materials to filter out bacteria.

Particulate Filtration Efficiency (PFE)

• The super high Particulate Filtration Efficiency (PFE) material of the ProShield N-95 fluid resistant face mask filters >99% of particles greater than 0.1 microns. When securely fitted, the ProShield N-95 fluid resistant face mask helps to provide an effective barrier to particulate matter from laser plumes and electrocautery procedures.

PFE measures effectiveness of the mask material to filter particulate matter.

Particulate Filter Respirator

• The ProShield N-95 fluid resistant face mask is NIOSH approved as a N-95 particulate filter respirator. It meets or exceeds the standard performance criteria demanded by NIOSH for the management of Tuberculosis (TB)

NIOSH – National Institute of Occupational Health and Safety (USA).

Fluid Resistance

• The fluid resistant qualities of the ProShield N-95 fluid resistant face mask provides protection against fluid strikethrough.

Fluid resistance is measured in accordance with ASTM F1862-98 & ASTM F1862-00a standard test method for resistance of medical face masks to penetration by synthetic blood at 16.0kPa pressure (120mmHg).

ProShield® N-95
72509- 09 Small
72509-10 Medium
Particulate filter respirator mask, fluid resistant, single pleated with bands
Areas of use
Provides high level of respiratory protection for clinicians/patients who are
potentially exposed to Tuberculosis (TB) or other infectious diseases.
≤5.1
FR 160mmHg
NIOSH Approved
P2 Compliant AS/NZS 1716:2012